Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.65 CHF | +1.09% | +0.25% | +16.96% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
Sales 2024 * | 10.29B 9.18B | Sales 2025 * | 10.96B 9.77B | Capitalization | 15.04B 13.42B |
---|---|---|---|---|---|
Net income 2024 * | 710M 633M | Net income 2025 * | 974M 869M | EV / Sales 2024 * | 1.76 x |
Net Debt 2024 * | 3.12B 2.78B | Net Debt 2025 * | 2.73B 2.44B | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
15.4
x | Employees | 22,633 |
Yield 2024 * |
1.82% | Yield 2025 * |
2.34% | Free-Float | 91.29% |
Latest transcript on Sandoz Group AG
1 day | +0.08% | ||
1 week | -0.82% | ||
Current month | -2.34% | ||
1 month | +1.00% | ||
3 months | +15.75% | ||
6 months | +18.20% | ||
Current year | +15.71% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 31.65 | +1.09% | 951 240 |
24-06-05 | 31.31 | +0.68% | 779,314 |
24-06-04 | 31.1 | +0.03% | 1,150,534 |
24-06-03 | 31.09 | -3.03% | 1,052,910 |
24-05-31 | 32.06 | +1.04% | 1,999,753 |
Delayed Quote Swiss Exchange, June 05, 2024 at 11:31 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.71% | 15.04B | |
+16.21% | 42.79B | |
+22.20% | 22.81B | |
+18.55% | 14.49B | |
+51.00% | 12.65B | |
-11.45% | 6.74B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.47B | |
+6.97% | 4.76B |
- Stock Market
- Equities
- SDZ Stock